Axis 2
Studiedness
- Evidence amount
- 0.00
- Direction balance
- The direction of the study results has not been extracted.
- PMID records loaded
- 0
- Records after title/year deduplication
- 0
entity · release 2026-09-20
Lacticaseibacillus casei KE-99
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Across the corpus
How this organism is actually sold
- Printed CFU per serving
- 4,000,000,000 – 200,000,000,000; median 102,000,000,000. Measured on the 2 of 2 published products carrying it whose latest published label prints a figure for it; the rest print a blend total or no quantity, and earlier label versions in the table below may print other figures. 0 row(s) print a CFU below 1 000 and are excluded as a label or parsing artefact.
- Forms
- Capsule: 2 · counted across the 2 of 2 published products whose label states a form
- Brands carrying it
- us-pharmaceutical-corporation (2)
- Published product pages
- 2
Products
Published products carrying this organism
| Product | Printed CFU | Printed dose | Cost per day | Form | Gut Index Score |
|---|---|---|---|---|---|
| US Pharmaceutical Corporation Provida OB | 200,000,000,000 | not printed | not observed | Capsule | 40.27 |
| US Pharmaceutical Corporation Restora | 4,000,000,000 | not printed | not observed | Capsule | 33.52 |
Containing labels8
Evidence amount0.00
Direction balanceThe direction of the study results has not been extracted.
Matched PubMed records
0 records (retracted records excluded; 0 retracted records match the query separately). PubMed query
Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.
No records match this query.
ClinicalTrials.gov
0 interventional studies. ClinicalTrials.gov query
This species has 32 tracked designations; this one appears on 8 labels (median 3).
Species and related strains
Axis 1 · inverted
Containing label versions
Showing 8 of 8 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.
| Brand | Product | DSLD | Gut Index Score | Strain named | Per-organism quantity | Potency basis | Versions |
|---|---|---|---|---|---|---|---|
| US Pharmaceutical Corporation | Provida OB | 241381 | 40.27 | true | 200,000,000,000 CFU | through expiry | 2 |
| US Pharmaceutical Corporation | Provida OB | 304795 | 40.27 | true | 200,000,000,000 CFU | through expiry | 2 |
| US Pharmaceutical Corporation | Fusion Plus | 82176 | 33.52 | true | 200,000,000,000 CFU | at manufacture | 1 |
| US Pharmaceutical Corporation | Fushion | 176235 | 33.52 | true | 200,000,000,000 CFU | at manufacture | 1 |
| US Pharmaceutical Corporation | Restora Rx | 264309 | 33.52 | true | 200,000,000,000 CFU | at manufacture | 2 |
| US Pharmaceutical Corporation | Restora | 264313 | 33.52 | true | 4,000,000,000 CFU | at manufacture | 2 |
| US Pharmaceutical Corporation | Restora | 264519 | 33.52 | true | 4,000,000,000 CFU | at manufacture | 2 |
| US Pharmaceutical Corporation | Restora RX | 264523 | 29.03 | true | 200,000,000,000 CFU | not stated | 2 |
Axis 3
Measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4
Reddit mention panel
0 observed mentions; no aggregate panel matched this entity.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps
Tools: DSLD product check · Unit value calculator
Citation
Cite this page
Ivitskiy, I. (2026). Lacticaseibacillus casei KE-99. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/lacticaseibacillus-casei-ke-99/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Lacticaseibacillus casei KE-99 appears on 8 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 1 brands; tied with 12 designations by distinct label count.
8 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324378 of 8 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Lacticaseibacillus casei KE-99 (100.0%); 0 light records have quantities unavailable.
8 / 8 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f732437No indexed strain-level randomized human trial report was found in this ledger version (as of 2026-09-15). 0 records (retracted records excluded; 0 retracted records match the query separately).
0 / 0 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
0 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 5 SKUs containing Lacticaseibacillus casei KE-99 have a numeric price observation (0.0%) in the release accompanying the NIH DSLD snapshot Sep 2026.
0 / 5 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437